OpGen to Present at Two Upcoming Investment Conferences in October
Get Alerts OPGN Hot Sheet
Join SI Premium – FREE
GAITHERSBURG, Md., Sept. 25, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) announced today that Evan Jones, Chairman and Chief Executive Officer, will present a corporate overview at two upcoming investment conferences, as follows:
| Ladenburg Thalmann 2018 Healthcare Conference | |||
| Date and Time: | Tuesday, October 2, 2018 at 1:30 p.m. Eastern time | ||
| Venue: | Sofitel New York Hotel in New York City | ||
| Dawson James Securities 4th Annual Small Cap Growth Conference | |||
| Date and Time: | Tuesday, October 30, 2018 at 10:30 a.m. Eastern time | ||
| Venue: | Wyndham Grand Jupiter Hotel in Jupiter, Florida | ||
To listen to the live presentations, investors may visit the Investor Relations section of OpGen’s website at www.opgen.com. An archived webcast of the presentations will also be available on the Company’s website for a period of time.
About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital, and network-wide infection prevention and treatment. For more information, please visit www.opgen.com.
OpGen Contact:
Michael Farmer
Vice President, Marketing
(240) 813-1284
[email protected]
[email protected]
Investor Contacts:
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
[email protected]
or
Bruce Voss
(310) 691-7100
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guelph Initiative Questions Whether OHIP Should Cover Psychotherapy
- Anderson Bradshaw Tax Consulting Expands Tax Resolution Focus as IRS Penalty Relief Changes Encourage Earlier Action
- The Wealth Company Launches Gift City Fund to Give NRIs a Single, Dollar-Denominated Route into India's Mutual Fund Market
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share